サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401356

脳腫瘍治療薬の世界市場規模調査＆予測、治療法別、適応症別、流通チャネル別、地域別分析、2023～2030年

Global Brain Tumor Drugs Market Size Study & Forecast, by Therapy, by Indication, by Distribution Channel and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
脳腫瘍治療薬の世界市場規模調査＆予測、治療法別、適応症別、流通チャネル別、地域別分析、2023～2030年
出版日: 2023年11月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳腫瘍治療薬市場は、2022年に約18億米ドルと評価され、予測期間2023～2030年には10.2％以上の健全な成長率で成長すると予測されています。

脳腫瘍は、脳またはその近傍に発生する細胞の異常増殖です。脳で発生する腫瘍は原発性脳腫瘍であり、身体の他の部位で発生する腫瘍は続発性または転移性脳腫瘍として知られています。腫瘍の大きさは、非常に小さいものから大きいものまで様々です。脳腫瘍の有病率の増加が市場成長の主要要因です。しかし、治療費の高さが市場拡大の妨げとなっています。

生活習慣の変化、急速な都市化、活発な喫煙者の割合の増加による脳腫瘍の有病率の上昇が市場成長の原動力となっています。Globocan 2020の推定によると、2021年には世界で30万8,102人の脳腫瘍患者が新たに発生し、25万1,329人が新たに死亡しました。米国がん協会によると、2021年には約2万4,530件の悪性脳腫瘍または脊髄腫瘍が診断され、さらに今年は15歳以下の小児3,460人が脳腫瘍または中枢神経系腫瘍と診断される見込みです。2020年8月の「COVID-19パンデミックの中での脳腫瘍管理」と題された調査によると、欧州腫瘍学会（ESMO）は腫瘍の進行を遅らせ、より長い生存期間を提供するための脳外科手術プロトコルを採用しています。この疾患とその治療に対する関心の高まりが、主要企業の研究開発への投資とともに市場を牽引しています。さらに、医薬品承認のための環境整備に向けた政府の取り組みが活発化していることや、これらの医薬品を開発する製薬企業の数が増加していることも、市場の成長を後押ししています。しかし、これらの薬剤に関連する副作用は、2023～2030年の予測期間を通じて市場成長の妨げとなっています。

脳腫瘍治療薬の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、米国の適切な償還政策と新薬の発売増加により、2022年の市場を独占しました。アジア太平洋は、様々な規制政策や、がんやその種類に関する意識の高まりにより、予測期間中に大きく成長すると予想されます。脳腫瘍研究機構によると、オーストラリアの脳腫瘍治療の平均評価は10点満点中8.37点と、すべてのがんの中で最低でした。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の脳腫瘍治療薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 脳腫瘍治療薬の世界市場力学

  • 脳腫瘍治療薬市場の影響分析（2020～2030年）
    • 市場の促進要因
      • 脳腫瘍患者の増加
      • 脳腫瘍に対する意識の高まり
      • 有力企業による強力な研究開発イニシアティブ
    • 市場の課題
      • 高い治療費
      • 治療に伴う副作用
    • 市場機会
      • 政府のイニシアチブの増加
      • 脳腫瘍治療薬を開発する製薬企業の増加

第4章 脳腫瘍治療薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 脳腫瘍治療薬の世界市場：治療法別

  • 市場スナップショット
  • 脳腫瘍治療薬の世界市場：治療法別、実績・ポテンシャル分析
  • 脳腫瘍治療薬の世界市場：治療法別、推定・予測、2020～2030年
  • 脳腫瘍治療薬の世界市場、サブセグメント別分析
    • 標的療法
    • 化学療法
    • 免疫療法
    • その他

第6章 脳腫瘍治療薬の世界市場：適応症別

  • 市場スナップショット
  • 脳腫瘍治療薬の世界市場：適応症別、実績・ポテンシャル分析
  • 脳腫瘍治療薬の世界市場：適応症別、推定・予測 2020～2030年
  • 脳腫瘍治療薬市場、サブセグメント分析
    • 下垂体
    • 髄膜腫
    • 神経膠腫
    • その他

第7章 脳腫瘍治療薬の世界市場：流通チャネル別

  • 市場スナップショット
  • 脳腫瘍治療薬の世界市場：流通チャネル別、実績・ポテンシャル分析
  • 脳腫瘍治療薬の世界市場：流通チャネル別、推定・予測、2020～2030年
  • 脳腫瘍治療薬市場、サブセグメント分析
    • 病院薬局
    • 小売・オンライン薬局

第8章 脳腫瘍治療薬の世界市場：地域別分析

  • 主要国
  • 主要新興国
  • 脳腫瘍治療薬の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 治療法、推定・予測、2020～2030年
      • 適応症、推定・予測、2020～2030年
      • 流通チャネル、推定・予測、2020～2030年
    • カナダ
  • 欧州の脳腫瘍治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の脳腫瘍治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの脳腫瘍治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Johnson & Johnson Services, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Bayer AG
    • F. Hoffmann-La Roche Ltd
    • Eisai Co. Ltd
    • Novartis AG
    • Merck & Co. Inc.
    • Amgen Inc.
    • AstraZeneca PLC,
    • Pfizer, Inc.
    • GlaxoSmithKline PLC

第10章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Brain Tumor Drugs Market, report scope
  • TABLE 2. Global Brain Tumor Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Brain Tumor Drugs Market estimates & forecasts by Therapy 2020-2030 (USD Billion)
  • TABLE 4. Global Brain Tumor Drugs Market estimates & forecasts by Indication 2020-2030 (USD Billion)
  • TABLE 5. Global Brain Tumor Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Brain Tumor Drugs Market
  • TABLE 71. List of primary sources, used in the study of global Brain Tumor Drugs Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Brain Tumor Drugs Market, research methodology
  • FIG 2. Global Brain Tumor Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Brain Tumor Drugs Market, key trends 2022
  • FIG 5. Global Brain Tumor Drugs Market, growth prospects 2023-2030
  • FIG 6. Global Brain Tumor Drugs Market, porters 5 force model
  • FIG 7. Global Brain Tumor Drugs Market, pest analysis
  • FIG 8. Global Brain Tumor Drugs Market, value chain analysis
  • FIG 9. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Brain Tumor Drugs Market, regional snapshot 2020 & 2030
  • FIG 15. North America Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Brain Tumor Drugs Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Brain Tumor Drugs Market is valued at approximately USD 1.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2023-2030. Brain tumors are abnormal growths of cells that develop in the brain or nearby areas. Tumors that develop in the brain is the primary brain tumor and tumor that begin in other parts of the body is known as secondary or metastatic brain tumors. The size of the tumor varies from very small size to large size. The increasing prevalence of brain tumors is a major contributing factor to the growth of the market. However, the high cost of treatments hinder market expansion.

The rising prevalence of brain cancer due to changing lifestyle habits, rapid urbanization, and increasing rate of active smokers is driving the market growth. According to Globocan 2020 estimates, there were 308,102 new cases of brain cancer worldwide in 2021, resulting in 251,329 new deaths. According to the American Cancer Society, around 24,530 malignant brain or spinal cord tumors were diagnosed in 2021, with an additional 3,460 children under the age of 15 expected to be diagnosed with brain or CNS tumors this year. The European Society for Medical Oncology (ESMO) has adopted a neurosurgery protocol to slow down tumor progression and provide a longer survival time, according to a research study titled "Brain Tumor Management Amidst COVID-19 Pandemic" in August 2020. The growing concern for the disease and its treatment is driving the market, along with key players investing in research and development. Furthermore, increasing government initiatives to provide a conducive environment for drug approval and the rising number of pharmaceutical companies developing these drugs propel the market growth. However, the side effects associated with these drugs hinder market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain Tumor Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to proper reimbursement policies in the U.S. and the increasing launch of new drugs. Asia Pacific is expected to grow significantly over the forecast period, due to varying regulatory policies and rising awareness about cancer and its types. According to the Brain Tumor Research Organization, Australia has average rating of brain tumor care was the lowest of all cancers, with a score of 8.37 out of 10.

Major market player included in this report are:

  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Eisai Co. Ltd
  • Novartis AG
  • Merck & Co. Inc.
  • Amgen Inc.
  • AstraZeneca PLC,
  • Pfizer, Inc.
  • GlaxoSmithKline PLC

Recent Developments in the Market:

  • In November 2021, Pfizer Inc. acquired Trillium Therapeutics, a clinical-stage immuno-oncology company that focuses primarily on developing innovative therapies for the treatment of cancer.
  • In September 2022, F. Hoffmann-La Roche Ltd. acquired Good Therapeutics, to gain rights to Good Therapeutics' platform technology, which has applications in various fields such as autoimmune diseases, pain management, metabolic diseases, and cancer.

Global Brain Tumor Drugs Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Therapy, Indication, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
  • Others

By Indication:

  • Pituitary
  • Meningioma
  • Glioma
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail & Online Pharmacy

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Brain Tumor Drugs Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Brain Tumor Drugs Market, by Therapy, 2020-2030 (USD Billion)
    • 1.2.3. Brain Tumor Drugs Market, by Indication, 2020-2030 (USD Billion)
    • 1.2.4. Brain Tumor Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Brain Tumor Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Brain Tumor Drugs Market Dynamics

  • 3.1. Brain Tumor Drugs Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of brain cancer cases
      • 3.1.1.2. Increasing awareness about the disease
      • 3.1.1.3. Strong R&D initiatives from strong players
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Therapy
      • 3.1.2.2. Side effects associated with the treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing government initiatives
      • 3.1.3.2. Increasing rate of pharmaceutical companies that are developing these drugs

Chapter 4. Global Brain Tumor Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Brain Tumor Drugs Market, by Therapy

  • 5.1. Market Snapshot
  • 5.2. Global Brain Tumor Drugs Market by Therapy, Performance - Potential Analysis
  • 5.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
  • 5.4. Brain Tumor Drugs Market, Sub Segment Analysis
    • 5.4.1. Targeted Therapy
    • 5.4.2. Chemotherapy
    • 5.4.3. Immunotherapy
    • 5.4.4. Others

Chapter 6. Global Brain Tumor Drugs Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Global Brain Tumor Drugs Market by Indication, Performance - Potential Analysis
  • 6.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
  • 6.4. Brain Tumor Drugs Market, Sub Segment Analysis
    • 6.4.1. Pituitary
    • 6.4.2. Meningioma
    • 6.4.3. Glioma
    • 6.4.4. Others

Chapter 7. Global Brain Tumor Drugs Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Brain Tumor Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Brain Tumor Drugs Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail & Online Pharmacy

Chapter 8. Global Brain Tumor Drugs Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Brain Tumor Drugs Market, Regional Market Snapshot
  • 8.4. North America Brain Tumor Drugs Market
    • 8.4.1. U.S. Brain Tumor Drugs Market
      • 8.4.1.1. Therapy breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Brain Tumor Drugs Market
  • 8.5. Europe Brain Tumor Drugs Market Snapshot
    • 8.5.1. U.K. Brain Tumor Drugs Market
    • 8.5.2. Germany Brain Tumor Drugs Market
    • 8.5.3. France Brain Tumor Drugs Market
    • 8.5.4. Spain Brain Tumor Drugs Market
    • 8.5.5. Italy Brain Tumor Drugs Market
    • 8.5.6. Rest of Europe Brain Tumor Drugs Market
  • 8.6. Asia-Pacific Brain Tumor Drugs Market Snapshot
    • 8.6.1. China Brain Tumor Drugs Market
    • 8.6.2. India Brain Tumor Drugs Market
    • 8.6.3. Japan Brain Tumor Drugs Market
    • 8.6.4. Australia Brain Tumor Drugs Market
    • 8.6.5. South Korea Brain Tumor Drugs Market
    • 8.6.6. Rest of Asia Pacific Brain Tumor Drugs Market
  • 8.7. Latin America Brain Tumor Drugs Market Snapshot
    • 8.7.1. Brazil Brain Tumor Drugs Market
    • 8.7.2. Mexico Brain Tumor Drugs Market
  • 8.8. Middle East & Africa Brain Tumor Drugs Market
    • 8.8.1. Saudi Arabia Brain Tumor Drugs Market
    • 8.8.2. South Africa Brain Tumor Drugs Market
    • 8.8.3. Rest of Middle East & Africa Brain Tumor Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Johnson & Johnson Services, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bayer AG
    • 9.3.3. F. Hoffmann-La Roche Ltd
    • 9.3.4. Eisai Co. Ltd
    • 9.3.5. Novartis AG
    • 9.3.6. Merck & Co. Inc.
    • 9.3.7. Amgen Inc.
    • 9.3.8. AstraZeneca PLC,
    • 9.3.9. Pfizer, Inc.
    • 9.3.10. GlaxoSmithKline PLC

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption